Eric Braakman Selected Research

Infections

1/2018	Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation.
12/2011	Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.
3/2007	Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation.
8/2005	A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Braakman Research Topics

Disease

4	Infections 01/2018 - 08/2005
4	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2009 - 01/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2020
2	Leukemia 01/2020 - 10/2003
2	Neuroblastoma 01/2019 - 11/2012
2	Neoplasms (Cancer) 01/2018 - 11/2012
1	Refractory Anemia 01/2020
1	Malignant Mesothelioma 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 11/2014
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2012
1	Wilms Tumor (Wilm's Tumor) 11/2012
1	Brain Neoplasms (Brain Tumor) 11/2012
1	Lymphoma (Lymphomas) 10/2003
1	Multiple Myeloma 10/2003

Drug/Important Bio-Agent (IBA)

2	Filgrastim (Neupogen)FDA Link 11/2012 - 10/2003
2	Fibroblast Growth Factor 7 FDA Link 06/2009 - 12/2007
1	Decitabine FDA Link 01/2020
1	PanobinostatIBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012

Therapy/Procedure

4	Transplantation 01/2018 - 08/2005
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2007 - 01/2002
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2012
2	Hematopoietic Stem Cell Transplantation 12/2011 - 08/2005
1	Therapeutics 01/2020
1	Blood Component Removal (Apheresis) 01/2019
1	Radiotherapy 01/2019
1	Immunotherapy 01/2018
1	Cord Blood Stem Cell Transplantation 01/2018
1	Chemoradiotherapy 10/2003
1	Homologous Transplantation 10/2003